Recommendations for the diagnosis and treatment of thoracic aorta diseases
DOI:
https://doi.org/10.6016/ZdravVestn.1482Keywords:
thoracic aortic aneurysm, dissection, diagnostics, treatmentAbstract
*NO ABSTRACT
Downloads
References
Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. Circulation. 2010; 121 (13): e266–369.
Cambria RA, Gloviczki P, Stanson AW, Cherry KJ Jr, Bower TC, Hallett JW Jr, et al. Outcome and expansion rate of 57 thoracoabdominal aortic aneurysms managed nonoperatively. Am J Surg. 1995; 170 (2): 213–7.
Coady MA, Rizzo JA, Hammond GL, Mandapati D, Darr U, Kopf GS, et al. What is the appropriate size criterion for resection of thoracic aortic aneurysms? J Torac Cardiovasc Surg. 1997; 113 (3): 476–91.
Davies RR, Goldstein LJ, Coady MA, Tittle SL, Rizzo JA, Kopf GS, et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Torac Surg. 2002; 73 (1): 17–27.
Baumgartner H, Bonhoeffer P, De Groot N, Haan F, Deanfeld JE, Galie N, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010) Te Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology. Eur Heart J. 2010; 31 (23): 2915–57.
Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Te Fifh Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012; 33 (13): 1635–701.
ALLHAT Ofcers and Coordinators for the ALLHAT Collaborative Research Group. Te Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: Te Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002; 288 (23): 2981–97.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration. Age-specifc relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360 (9349): 1903–13.
Neal B, MacMahon S, Chapman N. Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists’ Collaboration. Lancet. 2000; 356 (9246): 1955–64.
Ahimastos AA, Aggarwal A, D’Orsa KM, Formosa MF, White AJ, Savarirayan R, et al. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. JAMA. 2007; 298 (13): 1539–47.
Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC 3rd. Angiotensin II blockade and aortic-root dilation in Marfan’s syndrome. N Engl J Med. 2008; 358 (26): 2787-95.
Lacro RV, Dietz HC, Wruck LM, Bradley TJ, Colan SD, Devereux RB,et al. Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am Heart J. 2007; 154 (4): 624-31.
Evans J, Powell JT, Schwalbe E, Lofus IM, Tompson MM. Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue. Eur J Vasc Endovasc Surg. 2007; 34 (3): 302-3.
Kurzencwyg D, Filion KB, Pilote L, Nault P, Platt RW, Rahme E, et al. Cardiac medical therapy among patients undergoing abdominal aortic aneurysm repair. Ann Vasc Surg. 2006; 20 (5): 569-76.
Demers P, Miller DC, Mitchell RS, Kee ST, Sze D, Razavi MK, et al. Midterm results of endovascular repair of descending thoracic aortic aneurysms with frst generation stent grafs. J Torac Cardiovasc Surg. 2004; 127 (3): 664-73.
Khoynezhad A, Donayre CE, Bui H, Kopchok GE, Walot I, White RA. Risk factors of neurologic defcit afer thoracic aortic endografing. Ann Torac Surg. 2007; 83 (2): S882–9.
Clough RE, Mani K, Taylor PR. Toracic aortic pathology is key to choice treatment- for the motion. In: Greenalgh R, ed. Vascular and endovascular controversies update. BIBA Medical. 2012: 198–203.
Riga CV, Bicknell CD, Cheshire NJ. Hybrid and endovascular therapy for extensive thoracoabdominal aortic aneurysms. J Torac Cardiovasc Surg. 2010; 140 (6 Suppl): S168–70.
Gravereaux EC, Faries PL, Burks JA, Latessa V, Spielvogel D, Hollier LH, et al. Risk of spinal cord ischemia afer endograf repair of thoracic aortic aneurysms. J Vasc Surg. 2001; 34 (6): 997-1003.
Nienaber CA, Powell JT. Management of acute aortic syndromes. Eur Heart J. 2012; 33 (1): 26-35.
Meszaros I, Morocz J, Szlavi J, Schmidt J, Tornoci L, Nagy L, et al. Epidemiology and clinicopathology of aortic dissection. Chest. 2000; 117 (5): 1271-8.
Larson EW, Edwards WD. Risk factors for aortic dissection: a necropsy study of 161 cases. Am J Cardiol. 1984; 53 (6): 849-55.
Erbel R, Alfonso F, Boileau C, Dirsch O, Eber B, Haverich A, et al. Diagnosis and management of aortic dissection Recommendations of the Task Force on Aortic Dissection, European Society of Cardiology. Eur Heart J. 2001; 22 (18): 1642–81.
Song JK. Aortic intramural hematoma: aspects of pathogenesis 2011. Herz. 2011; 36 (6): 488-97.
Bischoff MS, Geisbüsch P, Peters AS, Hyhlik-Dürr A, Böckler D. Penetrating aortic ulcer: defning risks and therapeutic strategies. Herz. 2011; 36 (6): 498-504.
Fattori R, Cao P, De Rango P, Czerny M, Evangelista A, Nienaber C, et al. Interdisciplinary expert consensus document on management of type B aortic dissection. J Am Coll Cardiol. 2013; 61 (16): 1661-78.
Nienaber CA, Kische S, Rousseau H, Eggebrecht H, Rehders TC, Kundt G, et al. INSTEAD-XL trial. Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafs in aortic dissection trial. Circ Cardiovasc Intervl. 2013; 6 (4): 407-16.
Fattori R, Montgomery D, Lovato L, Kische S, Di Eusanio M, Ince H, et al. Survival afer endovascular therapy in patients with type B aortic dissection: a report from the International Registry of Acute Aortic Dissection (IRAD). JACC Cardiovasc Interv. 2013; 6 (8): 876-82.
Akin I, Kische S, Ince H, Nienaber C. Penetrating aortic ulcer, intramural hematoma, acute aortic syndrome: when to do what. Cardiovasc Surg (Torino). 2012; 53 (1 Suppl 1): 83-90.
Downloads
Published
Issue
Section
License
The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
